Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A

BRKRPNASDAQ
Healthcare
Medical - Devices
$309.90
$4.69(1.54%)
U.S. Market is Open • 13:57

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A Fundamental Analysis

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) shows moderate financial fundamentals with a PE ratio of -676.40, profit margin of -0.25%, and ROE of -0.40%. The company generates $3.4B in annual revenue with strong year-over-year growth of 13.56%.

Key Strengths

PEG Ratio-108.22
Current Ratio1.73

Areas of Concern

ROE-0.40%
Operating Margin5.44%
Cash Position0.65%
We analyze BRKRP's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 34.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
34.5/100

We analyze BRKRP's fundamental strength across five key dimensions:

Efficiency Score

Weak

BRKRP struggles to generate sufficient returns from assets.

ROA > 10%
-0.14%

Valuation Score

Excellent

BRKRP trades at attractive valuation levels.

PE < 25
-676.40
PEG Ratio < 2
-108.22

Growth Score

Moderate

BRKRP shows steady but slowing expansion.

Revenue Growth > 5%
13.56%
EPS Growth > 10%
-73.97%

Financial Health Score

Excellent

BRKRP maintains a strong and stable balance sheet.

Debt/Equity < 1
0.76
Current Ratio > 1
1.73

Profitability Score

Weak

BRKRP struggles to sustain strong margins.

ROE > 15%
-40.34%
Net Margin ≥ 15%
-0.25%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BRKRP Expensive or Cheap?

P/E Ratio

BRKRP trades at -676.40 times earnings. This suggests potential undervaluation.

-676.40

PEG Ratio

When adjusting for growth, BRKRP's PEG of -108.22 indicates potential undervaluation.

-108.22

Price to Book

The market values Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A at 2.35 times its book value. This may indicate undervaluation.

2.35

EV/EBITDA

Enterprise value stands at 13.43 times EBITDA. This signals the market has high growth expectations.

13.43

How Well Does BRKRP Make Money?

Net Profit Margin

For every $100 in sales, Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A keeps $-0.25 as profit after all expenses.

-0.25%

Operating Margin

Core operations generate 5.44 in profit for every $100 in revenue, before interest and taxes.

5.44%

ROE

Management delivers $-0.40 in profit for every $100 of shareholder equity.

-0.40%

ROA

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A generates $-0.14 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.14%

Following the Money - Real Cash Generation

Operating Cash Flow

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A generates limited operating cash flow of $133.93M, signaling weaker underlying cash strength.

$133.93M

Free Cash Flow

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A generates weak or negative free cash flow of $43.24M, restricting financial flexibility.

$43.24M

FCF Per Share

Each share generates $0.28 in free cash annually.

$0.28

FCF Yield

BRKRP converts 0.74% of its market value into free cash.

0.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-676.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-108.22

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.69

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.76

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How BRKRP Stacks Against Its Sector Peers

MetricBRKRP ValueSector AveragePerformance
P/E Ratio-676.4029.43 Better (Cheaper)
ROE-0.40%800.00% Weak
Net Margin-0.25%-20145.00% (disorted) Weak
Debt/Equity0.760.30 Weak (High Leverage)
Current Ratio1.734.64 Neutral
ROA-0.14%-17936.00% (disorted) Weak

BRKRP outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

69.18%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-40.26%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

22.66%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ